Myeloma Paper of the Day, July 10th, suggested by Robert Orlowski
Robert Orlowski shared on X:
“Myeloma Paper of the Day: Leukocyte immunoglobulin-like receptor B1 (LILRB1) protects human myeloma cells from ferroptosis by maintaining cholesterol homeostasis via LDLR and LDLRAP1 to facilitate LDL/cholesterol uptake, and could be a promising therapeutic target.”
Source: Robert Orlowski/X
Authors: Miao Xian, Qiang Wang, Liuling Xiao, Ling Zhong, Wei Xiong, Lingqun Ye, Pan Su, Chuanchao Zhang, Yabo Li, Robert Z. Orlowski, Fenghuang Zhan, Siddhartha Ganguly, Youli Zu, Jianfei Qian and Qing Yi.
Other posts featuring Robert Orlowski on OncoDaily.
Robert Orlowski holds multiple positions at The University of Texas MD Anderson Cancer Center, including Chairman, Ad Interim Director of Myeloma, and Professor of Medicine in the Departments of Lymphoma/Myeloma and Experimental Therapeutics within the Division of Cancer Medicine.
Additionally, he chairs the SWOG Barlogie/Salmon Myeloma Committee, which is part of the National Clinical Trials Network, dedicated to advancing new therapies and understanding the biology of myeloma.
